Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):344–350. doi: 10.1158/1055-9965.EPI-15-0470

Table 2.

Kaplan-Meier estimates with 95% confidence intervals of percent with follow-up colonoscopy at 1, 2, 3, 6, and 12 months after a positive fecal blood test in 2011–2012, by PROSPR healthcare system (N=62,384)

Healthcare system 1 month 2 months 3 months 6 months 12 months
Group Health 14.9 (13.5–16.2) 38.9 (36.9–40.8) 51.3 (49.3–53.3) 62.8 (60.7–64.7) 68.2 (66.0–70.1)
Kaiser Permanente Northern California 28.3 (27.8–28.8) 61.5 (61.0–62.0) 73.4 (72.9–73.9) 80.9 (80.5–81.3) 83.8 (83.4–84.3)
Kaiser Permanente Southern California 39.3 (38.7–39.9) 61.9 (61.3–62.5) 69.6 (69.0–70.2) 74.4 (73.8–74.9) 76.4 (75.8–76.9)
Parkland Health and Hospital System – University of Texas Southwestern Medical Center 2.4 (0.8–3.9) 17.0 (13.1–20.8) 34.7 (29.4–39.5) 50.2 (44.3–55.5) 58.1 (51.6–63.7)

PROSPR: Population-Based Research Optimizing Screening through Personalized Regimens